Director, Pharmacovigilance Scientist
- Salary
- $204K–$216K
- Hiring from
- United States
- Work type
- Hybrid
- Posted
625,140 remote jobs, straight from company career pages
100% free · New jobs every minute
Show job descriptionHide job description
BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENE™ platform, we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases.
Founded in 2016, BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.
What Are We Doing?
Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies.
We are passionate about realizing the promise of cell and gene therapy, shaping the future of regenerative medicine, and delivering new therapies to patients with limited or no treatment options.
Description of Position:
The Director, Pharmacovigilance Scientist, will lead pharmacovigilance activities for assigned development programs, providing both strategic and operational safety leadership. Focused on both neurology and ophthalmology therapeutic areas, this role will remain therapeutically flexible to meet organizational needs. The Director will act as the dedicated PV lead for assigned programs, partnering with Clinical Development MDs, Safety Physicians, Regulatory Affairs, Clinical Operations, and other cross-functional teams including interfacing with safety teams in the parent company, to ensure comprehensive oversight of safety deliverables, regulatory compliance, risk management, and inspection readiness.
Responsibilities:
- Serve as the PV lead for assigned programs, accountable for end-to-end safety deliverables including proactive signal detection, validation, evaluation, and tracking of emerging safety signals from clinical data sources; author signal evaluation reports; plan, author, and scientifically review aggregate safety reports; and lead development of risk management plans.
- Oversee the medical review of SAEs and ensure medically accurate narratives and consistent MedDRA coding.
- Facilitate internal Safety Management Teams (SMTs), and support Data Monitoring Committees (DMCs) by analyzing and evaluating safety data and presenting findings.
- Lead the preparation and PV input into core clinical trial documents, including study protocols, Investigator’s Brochures, ICFs, SAPs, CRFs, CSRs, author safety summaries for Health Authority submissions (including responses to safety inquiries) and regulatory filings, and labeling documents for assigned programs.
- Develop and maintain program-level PV strategies aligned with global regulatory requirements and company objectives.
- Lead PV contributions to regulatory authority interactions and audit and inspection readiness activities for assigned programs, ensuring compliance of safety documentation and SOPs with ICH guidelines and GVP.
- Partner with and oversee CROs and vendors handling case processing and manage SDEAs to ensure timely and compliant PV deliverables; monitor and track performance, and escalate issues as needed.
- Contribute to departmental process improvement and knowledge-sharing initiatives.
- Mentor junior staff or consultants supporting PV deliverables, and drive continuous improvement in PV systems.
Minimum Requirements:
- Advanced clinical or scientific degree in Pharmacy, Nursing, Epidemiology, Biosciences, or related healthcare discipline (PharmD, PhD, RN/MSN, or MD non-practicing/industry track).
- 10+ years of progressive in drug safety and pharmacovigilance within the pharmaceutical or biotechnology industry.
- Extensive, demonstrated, hands-on experience managing clinical trial safety (phases I-III) as the PV lead for global clinical programs across multiple phases.
- Strong, direct expertise in safety data evaluation, signal detection, signal evaluation, benefit-risk assessments, authoring and reviewing major clinical safety documents (IBs, RSI, protocols), aggregate reporting (DSURs), and regulatory submissions.
- Deep command of global PV regulations and guidelines, specifically FDA (21 CFR 312.32), EMA, and ICH guidelines for investigational products and Advanced Therapy Medicinal Products (ATMPs).
- Mastery of standard safety databases (e.g., Argus, Veeva Vault Safety) and medical coding dictionaries to execute complex search strategies.
- Proven ability to represent PV in cross-functional and external regulatory settings.
- Experience collaborating with and influencing senior cross-functional stakeholders in a matrix environment.
- Excellent communication, organizational, and leadership skills.
- Ability to manage competing priorities in a fast-paced, dynamic environment.
Desirable Skills Preferred:
- Experience in biologics Cell Therapy (e.g., iPSC, CAR-T) or Gene Therapy, and in long-term follow-up protocols, ability to distinguish between procedure-related vs. product-related AEs.
- Direct experience in neurology (especially neurodegenerative disorders) and/or ophthalmology (such as retinal diseases).
Equal Opportunity Workplace: At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.
We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.
About Us
BlueRock Therapeutics is a clinical stage cell therapy company focused on creating cellular medicines to treat devastating diseases. We are harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, one for the treatment of Parkinson’s disease and one for the treatment of primary photoreceptor diseases, are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG that invests in paradigm-shifting breakthrough innovation. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
